Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F23%3A00574532" target="_blank" >RIV/61388963:_____/23:00574532 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/86652036:_____/23:00574532

  • Výsledek na webu

    <a href="https://pubs.acs.org/doi/10.1021/acschembio.3c00212" target="_blank" >https://pubs.acs.org/doi/10.1021/acschembio.3c00212</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1021/acschembio.3c00212" target="_blank" >10.1021/acschembio.3c00212</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)

  • Popis výsledku v původním jazyce

    Histone deacetylase (HDAC) inhibitors used in the clinictypicallycontain a hydroxamate zinc-binding group (ZBG). However, more recentwork has shown that the use of alternative ZBGs, and, in particular,the heterocyclic oxadiazoles, can confer higher isoenzyme selectivityand more favorable ADMET profiles. Herein, we report on the synthesisand biochemical, crystallographic, and computational characterizationof a series of oxadiazole-based inhibitors selectively targeting theHDAC6 isoform. Surprisingly, but in line with a very recent findingreported in the literature, a crystal structure of the HDAC6/inhibitorcomplex revealed that hydrolysis of the oxadiazole ring transformsthe parent oxadiazole into an acylhydrazide through a sequence oftwo hydrolytic steps. An identical cleavage pattern was also observedboth in vitro using the purified HDAC6 enzyme aswell as in cellular systems. By employing advanced quantum and molecularmechanics (QM/MM) and QM calculations, we elucidated the mechanisticdetails of the two hydrolytic steps to obtain a comprehensive mechanisticview of the double hydrolysis of the oxadiazole ring. This was achievedby fully characterizing the reaction coordinate, including identificationof the structures of all intermediates and transition states, togetherwith calculations of their respective activation (free) energies.In addition, we ruled out several (intuitively) competing pathways.The computed data (& UDelta,G (& DDAG) & AP,21 kcal & BULL,mol(-1) for the rate-determining stepof the overall dual hydrolysis) are in very good agreement with theexperimentally determined rate constants, which a posteriori supports the proposed reaction mechanism. We also clearly (and quantitatively)explain the role of theCF3 orCHF2 substituent on the oxadiazole ring, which is a prerequisitefor hydrolysis to occur. Overall, our data provide compelling evidencethat the oxadiazole warheads can be efficiently transformed withinthe active sites of target metallohydrolases to afford reaction productspossessing distinct selectivity and inhibition profiles.

  • Název v anglickém jazyce

    Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)

  • Popis výsledku anglicky

    Histone deacetylase (HDAC) inhibitors used in the clinictypicallycontain a hydroxamate zinc-binding group (ZBG). However, more recentwork has shown that the use of alternative ZBGs, and, in particular,the heterocyclic oxadiazoles, can confer higher isoenzyme selectivityand more favorable ADMET profiles. Herein, we report on the synthesisand biochemical, crystallographic, and computational characterizationof a series of oxadiazole-based inhibitors selectively targeting theHDAC6 isoform. Surprisingly, but in line with a very recent findingreported in the literature, a crystal structure of the HDAC6/inhibitorcomplex revealed that hydrolysis of the oxadiazole ring transformsthe parent oxadiazole into an acylhydrazide through a sequence oftwo hydrolytic steps. An identical cleavage pattern was also observedboth in vitro using the purified HDAC6 enzyme aswell as in cellular systems. By employing advanced quantum and molecularmechanics (QM/MM) and QM calculations, we elucidated the mechanisticdetails of the two hydrolytic steps to obtain a comprehensive mechanisticview of the double hydrolysis of the oxadiazole ring. This was achievedby fully characterizing the reaction coordinate, including identificationof the structures of all intermediates and transition states, togetherwith calculations of their respective activation (free) energies.In addition, we ruled out several (intuitively) competing pathways.The computed data (& UDelta,G (& DDAG) & AP,21 kcal & BULL,mol(-1) for the rate-determining stepof the overall dual hydrolysis) are in very good agreement with theexperimentally determined rate constants, which a posteriori supports the proposed reaction mechanism. We also clearly (and quantitatively)explain the role of theCF3 orCHF2 substituent on the oxadiazole ring, which is a prerequisitefor hydrolysis to occur. Overall, our data provide compelling evidencethat the oxadiazole warheads can be efficiently transformed withinthe active sites of target metallohydrolases to afford reaction productspossessing distinct selectivity and inhibition profiles.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    10608 - Biochemistry and molecular biology

Návaznosti výsledku

  • Projekt

    Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2023

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    ACS Chemical Biology

  • ISSN

    1554-8929

  • e-ISSN

    1554-8937

  • Svazek periodika

    18

  • Číslo periodika v rámci svazku

    7

  • Stát vydavatele periodika

    US - Spojené státy americké

  • Počet stran výsledku

    17

  • Strana od-do

    1594-1610

  • Kód UT WoS článku

    001021443200001

  • EID výsledku v databázi Scopus

    2-s2.0-85164798151